Körber Joins National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Körber joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a community of manufacturers conducting groundbreaking research in big data, cell and gene therapy and other areas to advance U.S. manufacturing capabilities. The new membership marks an important step to strengthen networks and enable closer collaboration on leading biopharmaceutical manufacturing innovations. Körber looks forward to contributing its expertise in areas such as big data and cell and gene therapy, while building strong connections with other members of the NIIMBL community that will strengthen developments across the industry. Ruben Carbonell, Senior Technology Strategist at NIIMBL, said: "We are pleased to invite Körber, a leading service provider to the pharmaceutical industry including packaging, inspection and product handling technologies, to the NIIMBL member community. Körber's Business Area Pharma software products and services portfolio, which includes the Werum PAS-X MES manufacturing execution system and Werum PAS-X Savvy bioprocess data science software, will be a valuable contribution to the innovation technologies available through our network." Rachit Jain, Global Cell and Gene Lead Software at Körber Business Area Pharma, added: "As we continue our mission to save patients' lives, we are excited to join NIIMBL in our pursuit of solving the most challenging problems in bio-manufacturing, such as big data and cell & gene therapy initiatives. In this community, Körber will collaborate with community members like major pharma companies as well as with organizations such as NIST, FDA and BARDA as we race toward revolutionizing biopharmaceutical manufacturing."